ВИРУСНЫЙ ГЕПАТИТ Е: СОВРЕМЕННОЕ СОСТОЯНИЕ ПРОБЛЕМЫ
Аннотация
В данной статье представлен текущий статус проблемы вирусного гепатита Е. Вирусная инфекция гепатита Е традиционно считалась острой, самоограниченной болезнью, подобной гепатиту А. Вирус гепатита Е (ГЭВ) был признан десятилетиями как основная причина вспышек, связанных с фекальным загрязнением питьевой воды в развивающихся странах. Этот патоген теперь также признан в качестве основного этиологического агента острого гепатита в промышленно развитых странах, который передается зоонотически. Описан импортный случай ГЭВ на территории Республики Беларусь в сочетании с острой ВИЧ-инфекцией.
Литература
1. Khuroo MS, Teli MR, Skidmore S, Sofi MA, Khuroo MI. Incidence and severity of viral hepatitis in pregnancy. American Journal of Medicine. 1981;70(2):252-255.
2. Rein DB, Stevens GA, Theaker J, Wittenborn JS, Wiersma ST. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology, 2012;55(4):988-997.
3. Beyond the scope of the report: hepatitis A, D and E. Epidemiological update: increasing mortality calls for action. In: World Health Organization. Global hepatitis report, 2017 [Internet]. France: WHO Press; 2017. p. 5-21. URL: http://apps.who.int/iris/ bitstream/handle/10665/255016/9789241565455-eng.pdf;jsessio nid=9983C73B1690205E004BD6AE6346EF02?sequence=1/.
4. World Health Organization. Hepatitis E: Fact Sheer [Internet]. Geneva: WHO, 2017. URL: http://www.who.int/mediacentre/factsheets/fs280/en/.
5. Pischke S, Behrendt P, Bock CT, Jilg W, Manns MP, Wedemeyer H. Hepatitis E in Germany – an under-reported infectious disease. Deutsches Ärzteblatt International. 2014;111(35-36):577-583. doi: 10.3238/arztebl.2014.0577.
6. Рavio N, Meng XJ, Doceul V. Zoonotic origin of hepatitis E. Current Opinion in Virology. 2015;10:34-41. doi: 10.1016/j.coviro.2014.12.006.
7. Pavio N, Meng X-J, Renou C. Zoonotic hepatitis E: Animal reservoirs and emerging risks. Veterinary Research. 2010;41(6):46. doi: 10.1051/vetres/2010018.
8. Khuroo MS. Hepatitis E: the enterically transmitted non-A, non-B hepatitis. Indian Journal of Gastroenterology. 1991;10(3):96-100.
9. Khuroo MS, Duermeyer W, Zargar SA, Ahanger MA, Shah MA. Acute sporadic Non-A, non-B hepatitis in India. American Journal of Epidemiology. 1983;118:360-364.
10. Balayan MS. Virusnyj gepatit E. Rossijskij zhurnal gastrojenterologii, gepatologii, koloproktologi [Russian Journal of Gastroenterology, Hepatology, Coloproctology]. 1995;5(2):32-37. (Russian).
11. Balayan MS. Virus gepatita E u zhivotnyh. Mir virusnyh gepatitov. 2000;1:3-4. (Russian).
12. Bystrova TN, Poljanina AV, Knjagina ON. Harakteristika gepatita E-infekcii na territorii s umerennym klimatom. Medicinskij almanah. 2010;2:236-239. (Russian).
13. Bystrova TN, Poljanina AV, Knjagina ON. Kachestvennye i kolichestvennye parametry jepidemicheskogo processa gepatit E-infekcii na territorii Sredneevropejskogo regiona Rossii. Mir virusnyh gepatitov. 2010;1:9-13. (Russian).
14. Ahmad I, Holla RP, Jameel S. Molecular virology of hepatitis E virus. Virus Research. 2011;161:47-58. doi: 10.1016/j.virusres.2011.02.011.
15. Nan Y, Zhang Y-J. Molecular Biology and Infection of Hepatitis E Virus. Frontiers in Microbiology. 2016;7:1419. doi: 10.3389/fmicb.2016.01419.
16. Bamaud E, Rogee S, Garry P, Rose N, Pavio N. Thermal inactivation of infectious hepatitis E virus in experimentally contaminated food. Applied Environmental Microbiology. 2012;78:5153-5159. doi: 10.1128/AEM.00436-12.
17. Smith DB, Simmonds P, Jameel S, Emerson SU, Harrison TJ, Meng XJ, Okamoto H, Van der Poel WH, Purdy MA. Consensus proposals for classification of the family Hepeviridae. Journal of General Virology. 2014;95(Pt 10):2223-2232. doi: 10.1099/vir.0.068429-0.
18. International Committee on Taxonomy of Viruses, Hepatitis E virus [Internet]. 2015. URL: http://www.ictvonline.org/virusTaxInfo.asp.
19. Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Reviews in Medical Virology. 2006;16(1):5-36.
20. Wang Y, Ling R, Erker JC, Zhang H, Li H, Desai S, Mushahwar IK, Harrison TJ. A divergent genotype of hepatitis E virus in Chinese patients with acute hepatitis. Journal of General Virology. 1999;80(Pt 1):169-177.
21. Lhomme S, Marion O, Abravanel F, Chapuy-Regaud S, Kamar N, Izopet J. Hepatitis E Pathogenesis. Viruses. 2016;8(8):212.
22. Malinnikova E.Yu, Mikhaylov MI, Kyuregyan KK. Virusnyj gepatit E. Sovremennye predstavlenija ob jetiologii, jepidemiologii, diagnostike, klinike i profilaktike [Viral hepatitis E. Current concepts in the etiology, epidemiology, diagnosis, clinical findings and prevention]. Infekcionnye bolezni: novosti, mnenija, obuchenie bolezni [Infectious diseases: news, opinions, training]. 2014;3(8):13-22. (Russian).
23. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infectious Diseases. 2008;8(11):698-709.
24. Yugo DM, Cossaboom CM, Meng X-J. Naturally Occurring Animal Models of Human Hepatitis E Virus Infection. Institute of Laboratory Animal Resources Journal. 2014;55(1):187-199. doi: 10.1093/ilar/ilu007.
25. Solonin SA, Kjuregjan KK, Isaeva OV, Gruzdev KN, Mihajlov MI. Cirkuljacija virusa gepatita E v svinovodcheskom hozjajstve. Mir virusnyh gepatitov. 2009;3:37-38. (Russian).
26. Meng XJ, Wiseman B, Elvinger F, Guenette DK, Toth TE, Engle RE, Emerson SU, Purcell RH. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. Journal of Clinical Microbiology. 2002;40(1):117-122.
27. Gauss A, Wenzel JJ, Flechtenmacher C, Navid MH, Eisenbach C, Jilg W, Stremmel W, Schnitzler P. Chronic hepatitis E virus infection in a patient with leukemia and elevated transaminases: a case report. Journal of Medical Case Reports. 2012;6(1):334. doi: 10.1186/1752-1947-6-334.
28. Gotanda Y, Iwata A, Ohnuma H, Yoshikawa A, Mizoguchi H, Endo K, Takahashi M, Okamoto H. Ongoing subclinical infection of hepatitis E virus among blood donors with an elevated alanine aminotransferase level in Japan. Journal of Medical Virology. 2007;79:734-742.
29. Colson P, Borentain P, Queyriaux B, Kaba M, Moal V, Gallian P, Heyries L, Raoult D, Gerolami R. Pig liver sausage as a source of hepatitis E virus transmission to humans. Journal of Infectious Diseases. 2010;202(6):825-834.
30. Matsuda H, Okada K, Takahashi K, Mishiro S Severe hepatitis E virus infection after ingestion of uncooked liver from a wild boar. Journal of Infectious Diseases. 2003;188(6):944.
31. Arankalle VA, Chobe LP. Retrospective analysis of blood transfusion recipients: evidence for post-transfusion hepatitis E. Vox Sanguinis. 2000;79(2):72-74.
32. Matsubayashi K, Kang JH, Sakata H, Takahashi K, Shindo M, Kato M, Sato S, Kato T, Nishimori H, Tsuji K, Maguchi H, Yoshida J, Maekubo H, Mishiro S, Ikeda H. A case of transfusiontransmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion. 2008;48(7):1368-1375.
33. Khuroo MS, Kamili S, Jameel S. Association of severity of hepatitis E virus infection in the mother and vertically transmitted infection in the fetus. JK-Practitioner. 2006;13(2):70-74.
34. Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C, Dumortier J, Cannesson A,Cassuto-Viguier E, Thervet E, Conti F, Lebray P, Dalton HR, Santella R, Kanaan N, Essig M, Mousson C, Radenne S, Roque-Afonso AM, Izopet J, Rostaing L. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology. 2011;140(5):1481-1489. doi: 10.1053/j.gastro.2011.02.050.
35. Kamar N, Izopet J, Dalton HR. Chronic hepatitis E virus infection and treatment. Journal of Clinical and Experimental Hepatology. 2013;3:134-140. doi: 10.1016/j.jceh.2013.05.003.
36. Khuroo MS, Kamili S. Aetiology, clinical course and outcome of sporadic viral hepatitis in pregnancy. Journal of Viral Hepatitis. 2003;10:61-69.
37. Mahtab MA, Rahman S, Khan M, Karim F. HEV Infection as an Aetiologic Factor for Acute Hepatitis: Experience from a Tertiary Hospital in Bangladesh. Journal of Health, Population and Nutrition. 2009;27(1):14-19.
38. Mushahwar IK. Hepatitis E virus: molecular virology, clinical features, diagnosis, transmission, epidemiology, and prevention. Journal of Medical Virology. 2008;80(4):646-658.
39. Smith DB, Simmonds P. Hepatitis E virus and fulminant hepatitis-a virus or hostspecific pathology? [Internet]. Liver International. 2015;35(4):1334-1340. URL: https://onlinelibrary. wiley.com/doi/pdf/10.1111/liv.12629.
40. Malinnikova EYu, Koptyug VG, Potemkin IA, Ilchenko LYu, Mikhaylov MI. Nevrologicheskie projavlenija gepatita Е [Neurological manifestations of hepatitis Е]. Infekcionnye bolezni [Infectious Diseases]. 2013;11(1):16-20. (Russian).
41. Pischke S, Gisa A, Suneetha PV, Wiegand SB, Taubert R, Schlue J, Wursthorn K, Bantel H, Raupach R, Bremer B, Zacher BJ, Schmidt RE, Manns MP, Rifai K, Witte T, Wedemeyer H. Increased HEV seroprevalence in patients with autoimmune hepatitis. PLoS One. 2014;9(1):e85330.
42. Wedemeyer H, Pischke S, Manns MP. Pathogenesis and Treatment of Hepatitis E Virus Infection. Gastroenterology. 2012;142:1388-1397.
43. Kamili S. Towards the development of a hepatitis E vaccine. Virus Research. 2011;161:93-100.
44. Zhu FC, Zhang J, Zhang XF, Zhou C, Wang ZZ, Huang SJ, Wang H, Yang CL, Jiang HM, Cai JP, Wang YJ, Ai X, Hu YM, Tang Q, Yao X, Yan Q, Xian YL, Wu T, Li YM, Miao J, Ng MH, Shih JW, Xia NS. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomized, double-blind placebo-controlled phase 3 trial. Lancet. 2010;376(9744):890-902. doi: 10.1016/S0140-6736(10)61030-6.
45. Zhang J, Zhang XF, Huang SJ Wu T, Hu YM, Wang ZZ, Wang H, Jiang HM, Wang YJ, Yan Q, Guo M, Liu XH, Li JX, Yang CL, Tang Q, Jiang RJ, Pan HR, Li YM, Shih JW, Ng MH, Zhu FC, Xia NS. Long term efficacy of a hepatitis E vaccine. New England Journal of Medicine. 2015;372(10):914-922. doi: 10.1056/NEJMoa1406011.
2.png)
